Literature DB >> 3060993

On the mechanism of acute tolerance to furosemide diuresis.

P A Sjöström1, B G Odlind, B A Beermann, M Hammarlund-Udenaes.   

Abstract

The renal response to continuous furosemide infusion (8 mg/h) and subsequent ECV changes was studied in 8 healthy volunteers. Furosemide increased urine flow from a basal flow of 4.3 ml/min to a maximum of 15.4 ml/min. During dehydration (-1.8 kg) the diuresis decreased to 8.4 ml/min. The sodium, chloride and potassium excretion likewise decreased. This reduction in diuretic effect (acute tolerance) was accompanied by significantly increased plasma levels of norepinephrine (1.38 to 2.14 nmol/l), PRA (0.52 to 1.13 ng/ml/h) and aldosterone (0.29 to 0.45 nmol/l). After rehydration the urine flow increased to 23.1 ml/min. The changes in diuretic response from initial effect to the dehydrated state and after rehydration were mainly a consequence of changed renal sensitivity to furosemide (urinary excretion of 21 to 14 to 35 mumol Na+ per microgram furosemide excreted). It is proposed that activation of the sympathetic nervous system and/or the renin-angiotensin-aldosterone system may play a role in mediating the acute tolerance to furosemide diuresis. The relative importance of each remains to be clarified.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3060993     DOI: 10.1080/00365599.1988.11690399

Source DB:  PubMed          Journal:  Scand J Urol Nephrol        ISSN: 0036-5599


  12 in total

1.  The validity of the sigmoid Emax model and efficiency concept in diuretic studies.

Authors:  G Alván; M Hammarlund-Udenaes; B Odlind
Journal:  Br J Clin Pharmacol       Date:  1991-02       Impact factor: 4.335

2.  Response to furosemide during dehydration with and without naproxen pretreatment of kidney donors and renal transplant recipients.

Authors:  P A Sjöström; B G Odlind; M Hammarlund-Udenaes
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

3.  Absence of tolerance and toxicity to high-dose continuous intravenous furosemide in haemodynamically unstable infants after cardiac surgery.

Authors:  Maria M J van der Vorst; Joana E Kist-van Holthe; Jan den Hartigh; Albert J van der Heijden; Adam F Cohen; Jacobus Burggraaf
Journal:  Br J Clin Pharmacol       Date:  2007-04-18       Impact factor: 4.335

4.  Optimization of the therapeutic index by adjustment of the rate of drug administration or use of drug combinations: exploratory studies of diuretics.

Authors:  J Zhi; G Levy
Journal:  Pharm Res       Date:  1990-07       Impact factor: 4.200

5.  The influence of drug input rate on the development of tolerance to frusemide.

Authors:  M Wakelkamp; G Alván; H Scheinin; J Gabrielsson
Journal:  Br J Clin Pharmacol       Date:  1998-11       Impact factor: 4.335

Review 6.  Furosemide (frusemide). A pharmacokinetic/pharmacodynamic review (Part II).

Authors:  L L Ponto; R D Schoenwald
Journal:  Clin Pharmacokinet       Date:  1990-06       Impact factor: 6.447

7.  Understanding the hysteresis loop conundrum in pharmacokinetic/pharmacodynamic relationships.

Authors:  Christopher Louizos; Jaime A Yáñez; M Laird Forrest; Neal M Davies
Journal:  J Pharm Pharm Sci       Date:  2014       Impact factor: 2.327

8.  Changes in renal clearance of furosemide due to changes in renal blood flow and plasma albumin concentration.

Authors:  P A Sjöström; B G Kron; B G Odlind
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

Review 9.  Clinicopharmacological reappraisal of the potency of diuretics.

Authors:  A J Reyes; W P Leary
Journal:  Cardiovasc Drugs Ther       Date:  1993-01       Impact factor: 3.727

Review 10.  Influence of drug formulation on drug concentration-effect relationships.

Authors:  G Castañeda-Hernández; G Caillé; P du Souich
Journal:  Clin Pharmacokinet       Date:  1994-02       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.